Search This Blog

Thursday, February 28, 2019

MyoKardia reports Q4 EPS (39c), consensus (52c)

Reports Q4 revenue $12.4M, consensus $7.99M. Cash, cash equivalents and investments as of December 30, 2018 were $394.8M, compared to $276.4M as of December 31, 2017. The increase in the company’s cash position is primarily attributable to proceeds received from a follow-on offering of common stock in May 2018.
https://thefly.com/landingPageNews.php?id=2872167

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.